Fig. 13From: Solid form changes during drug development: good, bad, and ugly case studiesMean olanzapine plasma concentrations for the Multiple-Dose Group receiving 405 mg/4 weeks; arrows along x-axis indicate injections (adapted from reference (Agency et al. 2015))Back to article page